STAMBP and schizophrenia: No significant correlation was found between psychiatric symptoms or cognitive function scores and plasma neuropeptide (i.e., α‐MSH, β‐endorphin, neurotensin, oxytocin, and substance P) levels in patients with schizophrenia, BD, or MDD, or healthy controls.